CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0200
-0.0100 (-33.33%)
Aug 17, 2026, 3:30 PM EST
CV Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12.74 | 13.79 | 15.71 | 16 | 16.21 | 20.05 | |
Revenue Growth | -14.90% | -12.20% | -1.87% | -1.24% | -19.17% | -17.93% |
Cost of Revenue | 6.48 | 7.04 | 8.54 | 8.92 | 10.66 | 11.43 |
Gross Profit | 6.26 | 6.75 | 7.17 | 7.09 | 5.55 | 8.62 |
Selling, General & Admin | 7.15 | 7.62 | 8.42 | 9.49 | 13.37 | 20.84 |
Research & Development | 0.08 | 0.12 | 0.12 | 0.15 | 0.31 | 1.19 |
Other Operating Expenses | - | -0.52 | - | -6.17 | - | - |
Operating Expenses | 7.23 | 7.22 | 8.54 | 3.47 | 13.68 | 22.03 |
Operating Income | -0.97 | -0.47 | -1.37 | 3.61 | -8.13 | -13.41 |
Interest Expense | -0.33 | -0.52 | -0.21 | -0.06 | -1.54 | -0.14 |
Other Non Operating Income (Expenses) | - | - | - | -0.2 | - | - |
EBT Excluding Unusual Items | -1.3 | -0.99 | -1.59 | 3.35 | -9.67 | -13.55 |
Impairment of Goodwill | - | - | - | - | - | -2.79 |
Legal Settlements | - | - | -0.83 | - | - | - |
Other Unusual Items | -0.7 | 0.04 | 0.01 | - | 1.72 | 2.95 |
Pretax Income | -2 | -0.95 | -2.4 | 3.1 | -9.18 | -15.64 |
Income Tax Expense | 0.01 | 0.01 | -0.01 | -0.01 | -0.05 | -0.09 |
Net Income | -2.01 | -0.96 | -2.39 | 3.1 | -9.13 | -15.55 |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.92 | - |
Net Income to Common | -2.01 | -0.96 | -2.39 | 3.1 | -10.05 | -15.55 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 192 | 184 | 176 | 154 | 138 | 108 |
Shares Outstanding (Diluted) | 192 | 184 | 176 | 154 | 138 | 108 |
Shares Change | 4.24% | 4.94% | 14.05% | 11.53% | 28.03% | 7.91% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | 0.02 | -0.07 | -0.14 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | 0.02 | -0.07 | -0.14 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -0.52 | -0.52 | -0.88 | 2.25 | -1.89 | -7.52 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | 0.01 | -0.01 | -0.07 |
Gross Margin | 49.14% | 48.97% | 45.64% | 44.27% | 34.25% | 42.98% |
Operating Margin | -7.60% | -3.41% | -8.75% | 22.56% | -50.16% | -66.90% |
Profit Margin | -15.74% | -6.95% | -15.24% | 19.38% | -62.04% | -77.58% |
Free Cash Flow Margin | -4.10% | -3.74% | -5.60% | 14.08% | -11.63% | -37.51% |
EBITDA | -0.87 | -0.28 | -1.04 | 3.85 | -7.14 | -12.26 |
EBITDA Margin | -6.84% | -2.02% | -6.62% | 24.03% | -44.04% | -61.15% |
D&A For EBITDA | 0.1 | 0.19 | 0.33 | 0.24 | 0.99 | 1.15 |
EBIT | -0.97 | -0.47 | -1.37 | 3.61 | -8.13 | -13.41 |
EBIT Margin | -7.60% | -3.41% | -8.75% | 22.56% | -50.16% | -66.90% |
Advertising Expenses | - | 0.1 | 0.5 | 1.1 | 1.2 | 1.3 |